Table 2

Primary patient-relevant outcomes of the trial at 60 month follow-up.

Primary outcomes (adjusted)APM
(n=68)
Placebo surgery
(n=74)
Between-group difference in
improvement from baseline
WOMET score*84.3 (80.1 to 88.6)84.6 (80.5 to 88.7)−1.7 (−7.7 to 4.3)
Lysholm knee score†83.7 (80.3 to 87.1)85.8 (82.6 to 89.0)−2.1 (−6.8 to 2.6)
Knee pain after exercise‡2.0 (1.5 to 2.6)2.2 (1.6 to 2.7)−0.04 (−0.81 to 0.72)
  • Values are presented as means (95% CI).

  • *The Western Ontario Meniscal Evaluation Tool (WOMET) contains 16 items addressing three domains: 9 items addressing physical symptoms; 4 items addressing disabilities with regard to sports, recreation, work, and lifestyle; and 3 items addressing emotions. The score indicates the percentage of a normal score; therefore, 100 is the best possible score, and 0 is the worst possible score.

  • †The Lysholm knee score is based on an eight-item questionnaire designed to evaluate knee function and symptoms in activities of daily living. Scores range from 0 to 100; higher scores indicate less severe symptoms.

  • ‡Knee pain after exercise (during the preceding week) was assessed on a rating scale of 0 to 10, with 0 denoting no pain and 10 denoting extreme pain.

  • APM, arthroscopic partial meniscectomy.